JPS6322262B2 - - Google Patents
Info
- Publication number
- JPS6322262B2 JPS6322262B2 JP55181051A JP18105180A JPS6322262B2 JP S6322262 B2 JPS6322262 B2 JP S6322262B2 JP 55181051 A JP55181051 A JP 55181051A JP 18105180 A JP18105180 A JP 18105180A JP S6322262 B2 JPS6322262 B2 JP S6322262B2
- Authority
- JP
- Japan
- Prior art keywords
- bilirubin
- reagent
- direct
- measurement
- indirect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000008789 Direct Bilirubin Methods 0.000 claims description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 238000005259 measurement Methods 0.000 claims description 14
- OIPQQYMMNLZAHN-UHFFFAOYSA-N naphthalene-1,5-disulfonate;4-sulfobenzenediazonium Chemical compound OS(=O)(=O)C1=CC=C([N+]#N)C=C1.OS(=O)(=O)C1=CC=C([N+]#N)C=C1.C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1S([O-])(=O)=O OIPQQYMMNLZAHN-UHFFFAOYSA-N 0.000 claims description 4
- YZMHQCWXYHARLS-UHFFFAOYSA-N naphthalene-1,2-disulfonic acid Chemical compound C1=CC=CC2=C(S(O)(=O)=O)C(S(=O)(=O)O)=CC=C21 YZMHQCWXYHARLS-UHFFFAOYSA-N 0.000 claims 1
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 54
- 238000000034 method Methods 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000012954 diazonium Substances 0.000 description 11
- 150000001989 diazonium salts Chemical class 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 6
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- UNKYOXKQMHLGPW-UHFFFAOYSA-N Urobilin IXalpha Natural products CCC1=C(C)C(=O)NC1CC2=NC(=Cc3[nH]c(CC4NC(=O)C(=C4C)CC)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O UNKYOXKQMHLGPW-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- KDCCOOGTVSRCHX-UHFFFAOYSA-N urobilin Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(CC3C(=C(CC)C(=O)N3)C)=N2)CCC(O)=O)N1 KDCCOOGTVSRCHX-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- UEUIKXVPXLWUDU-UHFFFAOYSA-N 4-diazoniobenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=C([N+]#N)C=C1 UEUIKXVPXLWUDU-UHFFFAOYSA-N 0.000 description 1
- MVAFULKLPSJSGW-UHFFFAOYSA-N 4-sulfobenzenediazonium;chloride Chemical compound [Cl-].OS(=O)(=O)C1=CC=C([N+]#N)C=C1 MVAFULKLPSJSGW-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000008049 diazo compounds Chemical group 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000008134 glucuronides Chemical group 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XTEGVFVZDVNBPF-UHFFFAOYSA-L naphthalene-1,5-disulfonate(2-) Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1S([O-])(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-L 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/728—Bilirubin; including biliverdin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
本発明は直接ビリルビン測定用試薬に関するも
のである。
体液中のビリルビンには間接型と直接型があ
り、間接ビリルビンは非抱合型ビリルビン(遊離
ビリルビン)であり、直接ビリルビンは抱合型ビ
リルビンであつて、前記遊離ビリルビンの側鎖の
プロピオン酸がグルクロン酸とエステル結合した
グルクロナイド(モノグルクロナイド、ジグルク
ロナイド等)である。総ビリルビンは直接ビリル
ビンと間接ビリルビンの総称である。
体液中に各種のビリルビンの病態時に臨床検査
として測定されるものは血中ビリルビン濃度とそ
の分画(直接型ビリルビンと間接型ビリルビン)、
尿中ビリルビンおよびウロビリン体、糞便中のウ
ロビリン体などが主であつて、このうち血中ビリ
ルビンの動態は最も重要で、各種黄疸の分類、鑑
別に重要な意義をもつている。また近年Rh不適
合による胎児の溶血性疾患の重症度の判定や対策
などに羊水中のビリルビンの分析が重要視されて
いる。
ビリルビンのジアゾ化反応を利用した測定法は
1910年代にHIJMANS VAN DEN BERGHら
により考案され、1930年代にMALLOY,EVE―
LYN,JENDRASSIK,GROFらにより定量法
として確立されて以来、多くの改良法が提案され
ているが、現在もなお、この測定原理を利用した
方法が臨床分析の主流を占めている。
この古典的な測定方法とはジアゾニウム塩を用
いるとき、スルフアニル酸と亜硝酸を反応させて
調製する方法である。そして、この改良方法の1
つとして、KULHANEKら、
ERTHINGHAUSENらによつて提案された安定
化ジアゾニウム塩を用いる方法がある。この改良
法は予め作成した安定化ジアゾニウム塩粉末を緩
衝液に溶解するだけで、試薬調製ができるという
優れた方法である。しかしながら、この改良法で
は総ビリルビンのみの測定で、直接ビリルビンの
測定は行なわれていない。ここで安定化ジアゾニ
ウム塩とは、ジアゾ化合物とナフタリンスルホン
酸塩、塩化亜鉛との複塩、フツ化ホウ素酸塩など
で、固体状態で分離されたものである。
一方、総ビリルビンおよび直接ビリルビンの分
画測定法として、安部らによつて安定化ジアゾニ
ウム塩の1種、p―スルホベンゼンジアゾニウ
ム、1,5―ナフタレンジスルホン酸塩を用いる
方法が提案されている。ところが、該安定化ジア
ゾニウム塩を3.4ミリモル/用いるこの直接ビ
リルビン測定法では間接ビリルビンが強く発色し
て、直接ビリルビン値として過大な測定値を与え
るという欠点がある。
本発明者らはこのような欠点を改良するため
に、種々鋭意検討したところ、安定化ジアゾニウ
ム塩の濃度が該試薬に対して、特定の濃度に調製
することにより、間接ビリルビンの直接反応が問
題ない程度にまで抑制されることを見出し、本発
明に到達した。すなわち本発明はp―スルホベン
ゼンジアゾニウム―1,5―ナフタレンジスルホ
ン酸塩および塩酸を含有する直接ビリルビン測定
用試薬において、p―スルホベンゼンジアゾニウ
ム―1,5―ナフタレンジスルホン酸塩が該測定
用試薬に対して0.05〜1.0ミリモル/含有され
ていることを特徴とする直接ビリルビン測定用試
薬である。
本発明では間接ビリルビンの直接ビリルビン反
応を問題ない程度にまで抑制させることにより正
確に直接ビリルビンを測定することができるほか
に、従来の方法、例ええばアルコールをカツプリ
ング試薬とするMALLOY―EVELYN法、カフ
エイン―安息香酸をカツプリング試薬とし、ジア
ゾ発色後フエーリング液を加えアルカリアゾビ
リルビンとして比色するJENDRASSIK―GROF
法およびそれらの改良法ではジアゾニウム塩の濃
度は調整時、亜硝酸ナトリウムの量によつて決ま
るため、通常1.8〜2.9ミリモル/程度であるの
に対し、本発明では安定化ジアゾニウム塩を従来
より低濃度で測定することが可能となる。通常、
臨床分析において血清中の総ビリルビンおよび直
接ビリルビンは一般に0.1〜40mg/dlの範囲のも
のを定量するが、本発明試薬では充分、この範囲
のものを測定することができる。
本発明の直接ビリルビン測定用試薬は安定化ジ
アゾニウム塩と塩酸とを含む。
塩酸は0.01乃至0.10規定の範囲が望ましい。
本発明に用いる安定化p―スルホベンゼンジア
ゾニウムクロリドを1,5―ナフタレンジスルホ
ン酸で安定したp―スルホベンゼンジアゾニウム
―1,5―ナフタレンジスルホン酸塩である。
本発明では安定化ジアゾニウム塩の濃度を直接
ビリルビン測定用試薬に対して、0.05〜1.0ミリ
モル/であることを特徴とする。この範囲の濃
度において間接ビリルビンの直接ビリルビン反応
に対する影響を抑制することができる。0.05ミリ
モル/未満であると、直接ビリルビンの測定を
行なうことが出来ず、1.0ミリモル/を越える
と間接ビリルビンの影響が大きく、正確な直接ビ
リルビンの測定を行なうことができない。
参考例
間接ビリルビン溶液の作成
EDTA・Na20.1g、無水炭酸ナトリウム1.06g
を蒸溜水800mlに溶解し、結晶ビリルビン0.2gを
溶解し、次いでヒト血清アルブミン55gを溶解
し、蒸溜水を加え1000ml定容とした。この液の3
ml毎をバイアル瓶に分注して後凍結真空乾燥し密
栓し冷暗所に保存した。使用時に凍結乾燥品を3
mlの蒸溜水で再溶解した。
実施例 1
間接ビリルビンの直接ビリルビン測定試薬にお
ける反応性
直接ビリルビン測定反応試薬として、0.025規
定の塩酸水溶液に第1表に示される種々の量のp
―スルホベンゼンジアゾニウム―1,5―ナフタ
レンジスルホン酸塩(以下NDDSと略す)を溶
解して調製した。
参考例で調整した間接ビリルビン溶液50μ
に、上記反応試薬3mlを添加し、37℃で15分間加
温し、波長560nmにおける吸光度を測定した。試
薬ブランクとの吸光度差△ODdを求めた。
一方、総ビリルビン測定反応試薬として、0.1
規定塩酸およびジメチルスルホキシド30%を含有
する水溶液1に第1表に示される種々の量の
NDDSを溶解して調製した。参考例1で調整し
た間接ビリルビン溶液50μに、この反応試薬3
mlを添加し、37℃で15分間加温し、波長560nmに
おける吸光度を測定した。試薬ブランクとの吸光
度差△ODtを求めた。
間接ビリルビンの直接反応率を△ODd/△ODt
により表わす。その結果を第1表に示す。
The present invention relates to a reagent for direct bilirubin measurement. There are two types of bilirubin in body fluids: indirect and direct. Indirect bilirubin is unconjugated bilirubin (free bilirubin), and direct bilirubin is conjugated bilirubin, in which the propionic acid in the side chain of free bilirubin is glucuronic acid. It is a glucuronide (monoglucuronide, diglucuronide, etc.) that has an ester bond with. Total bilirubin is a general term for direct bilirubin and indirect bilirubin. The blood bilirubin concentration and its fractions (direct bilirubin and indirect bilirubin) are measured in clinical tests during various pathological conditions of bilirubin in body fluids.
The main components are bilirubin and urobilin bodies in urine and urobilin bodies in feces, and among these, the dynamics of bilirubin in blood is the most important and has important significance in the classification and differentiation of various types of jaundice. In addition, in recent years, analysis of bilirubin in amniotic fluid has become important for determining the severity of fetal hemolytic disease due to Rh incompatibility and for countermeasures. The measurement method using the diazotization reaction of bilirubin is
It was invented by HIJMANS VAN DEN BERGH and others in the 1910s, and MALLOY, EVE in the 1930s.
Since it was established as a quantitative method by LYN, JENDRASSIK, GROF, and others, many improved methods have been proposed, but methods that utilize this measurement principle still dominate clinical analysis. This classical measurement method is a method in which diazonium salts are prepared by reacting sulfanilic acid with nitrous acid. And this improvement method 1
As one, KULHANEK et al.
There is a method using a stabilized diazonium salt proposed by ERTHINGHAUSEN et al. This improved method is an excellent method in that the reagent can be prepared simply by dissolving the stabilized diazonium salt powder prepared in advance in a buffer solution. However, this improved method measures only total bilirubin and does not directly measure bilirubin. Here, the stabilized diazonium salt is a diazo compound and a naphthalene sulfonate, a double salt with zinc chloride, a fluoroborate, etc., which are separated in a solid state. On the other hand, as a fractional measurement method for total bilirubin and direct bilirubin, Abe et al. have proposed a method using one of the stabilized diazonium salts, p-sulfobenzenediazonium and 1,5-naphthalenedisulfonate. However, this direct bilirubin measuring method using 3.4 mmol of the stabilized diazonium salt has the disadvantage that indirect bilirubin develops a strong color, giving an excessively high measured value as the direct bilirubin value. The inventors of the present invention have made extensive studies in order to improve these drawbacks, and have found that by adjusting the concentration of the stabilizing diazonium salt to a specific concentration for the reagent, the direct reaction of indirect bilirubin can be prevented. The present invention has been achieved based on the discovery that this can be suppressed to an extent that does not occur. That is, the present invention provides a direct bilirubin measurement reagent containing p-sulfobenzenediazonium-1,5-naphthalenedisulfonate and hydrochloric acid, in which p-sulfobenzenediazonium-1,5-naphthalenedisulfonate is included in the measurement reagent. This reagent for direct bilirubin measurement is characterized in that it contains 0.05 to 1.0 mmol per bilirubin. In addition to being able to accurately measure direct bilirubin by suppressing the direct bilirubin reaction of indirect bilirubin to a non-problematic level, the present invention can also be performed using conventional methods, such as the MALLOY-EVELYN method using alcohol as a coupling reagent, and the method using caffeine as a coupling reagent. -JENDRASSIK using benzoic acid as a coupling reagent and adding Fehling's solution after diazo color development to compare the color as alkaline azobilirubin-GROF
In the methods and their improved methods, the concentration of the diazonium salt is determined by the amount of sodium nitrite at the time of adjustment, and is usually about 1.8 to 2.9 mmol/millimol/m; in contrast, in the present invention, the stabilized diazonium salt is It becomes possible to measure by concentration. usually,
In clinical analysis, total bilirubin and direct bilirubin in serum are generally determined in the range of 0.1 to 40 mg/dl, and the reagent of the present invention can satisfactorily measure amounts in this range. The reagent for direct bilirubin measurement of the present invention contains a stabilized diazonium salt and hydrochloric acid. Hydrochloric acid is preferably in the range of 0.01 to 0.10 normal. The stabilized p-sulfobenzenediazonium chloride used in the present invention is p-sulfobenzenediazonium-1,5-naphthalenedisulfonic acid salt stabilized with 1,5-naphthalenedisulfonic acid. The present invention is characterized in that the concentration of the stabilized diazonium salt is 0.05 to 1.0 mmol per reagent for direct bilirubin measurement. In this concentration range, the influence of indirect bilirubin on the direct bilirubin reaction can be suppressed. If it is less than 0.05 mmol/, direct bilirubin cannot be measured, and if it exceeds 1.0 mmol/, the influence of indirect bilirubin will be large and accurate direct bilirubin cannot be measured. Reference example: Preparation of indirect bilirubin solution EDTA・Na 2 0.1g, anhydrous sodium carbonate 1.06g
was dissolved in 800 ml of distilled water, 0.2 g of crystalline bilirubin was dissolved, and then 55 g of human serum albumin was dissolved, and distilled water was added to make a constant volume of 1000 ml. 3 of this liquid
Each ml was dispensed into vials, freeze-dried in vacuum, sealed tightly, and stored in a cool, dark place. Freeze-dried product at the time of use
ml of distilled water. Example 1 Reactivity of indirect bilirubin in direct bilirubin measurement reagent As a direct bilirubin measurement reaction reagent, various amounts of p shown in Table 1 were added to a 0.025N hydrochloric acid aqueous solution.
It was prepared by dissolving -sulfobenzenediazonium-1,5-naphthalenedisulfonate (hereinafter abbreviated as NDDS). Indirect bilirubin solution prepared in reference example 50μ
3 ml of the above reaction reagent was added, heated at 37°C for 15 minutes, and absorbance at a wavelength of 560 nm was measured. The absorbance difference ΔODd with respect to the reagent blank was determined. On the other hand, as a reaction reagent for measuring total bilirubin, 0.1
In an aqueous solution 1 containing normal hydrochloric acid and 30% dimethyl sulfoxide, various amounts of
Prepared by dissolving NDDS. Add this reaction reagent 3 to 50μ of the indirect bilirubin solution prepared in Reference Example 1.
ml was added, heated at 37°C for 15 minutes, and absorbance at a wavelength of 560 nm was measured. The absorbance difference ΔODt with respect to the reagent blank was determined. Direct reaction rate of indirect bilirubin is △ODd/△ODt
It is expressed by The results are shown in Table 1.
【表】
第1表から明らかなようにNDDS濃度が約1.0
ミリモル/を越えると、間接ビリルビンの直接
反応は30%以上となり好ましくない。
実施例 2
直接ビリルビンの直接反応の反応性
直接ビリルビン測定反応試薬として、0.01規定
塩酸水溶液1にNDDS0.15ミリモル(及び参考
例として0.02ミリモル)を溶解して調整した。
試料(MALLOY―EVELYNの方法で測定し
た直接ビリルビン値39.3mg/dl)蒸溜水で希釈し
第2表に示される希釈系列を作成した。この希釈
試料50μに対し、上記直接ビリルビン測定試薬
3mlを加え、37℃で5分間加温した後、波長
560nmの吸光度を測定した。その結果を第2表に
示す。[Table] As is clear from Table 1, the NDDS concentration is approximately 1.0
If it exceeds mmol/millimol/millimol/m, the direct reaction of indirect bilirubin will be more than 30%, which is not preferable. Example 2 Reactivity of direct bilirubin direct reaction A reaction reagent for direct bilirubin measurement was prepared by dissolving 0.15 mmol of NDDS (and 0.02 mmol as a reference example) in 1 part of a 0.01 N hydrochloric acid aqueous solution. A sample (direct bilirubin value 39.3 mg/dl measured by the MALLOY-EVELYN method) was diluted with distilled water to create the dilution series shown in Table 2. Add 3 ml of the above direct bilirubin measurement reagent to 50μ of this diluted sample, heat it at 37°C for 5 minutes, and then
Absorbance at 560 nm was measured. The results are shown in Table 2.
【表】
第2表から明らかなように、希釈度に対して吸
光度は直線的に変化している。
一方、NDDS濃度が低い参考例では発色度が
低い直線性が劣る。[Table] As is clear from Table 2, the absorbance changes linearly with the degree of dilution. On the other hand, the reference example with a low NDDS concentration has a low degree of color development and poor linearity.
Claims (1)
ナフタレンジスルホン酸塩および塩酸を含有する
直接ビルリビン測定用試薬において、p―スルホ
ベンゼンジアゾニウム―1,5―ナフタレンジス
ルホン酸塩が該測定用試薬に対して0.05〜1.0ミ
リモル/含有されていることを特徴とする直接
ビリルビン測定用試薬。1 p-sulfobenzenediazonium-1,5-
A reagent for direct bilibin measurement containing naphthalene disulfonate and hydrochloric acid, characterized in that p-sulfobenzenediazonium-1,5-naphthalene disulfonate is contained in a proportion of 0.05 to 1.0 mmol/based on the measurement reagent. A reagent for direct bilirubin measurement.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18105180A JPS57103056A (en) | 1980-12-19 | 1980-12-19 | Reagent for measuring direct bilirubin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18105180A JPS57103056A (en) | 1980-12-19 | 1980-12-19 | Reagent for measuring direct bilirubin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57103056A JPS57103056A (en) | 1982-06-26 |
JPS6322262B2 true JPS6322262B2 (en) | 1988-05-11 |
Family
ID=16093910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18105180A Granted JPS57103056A (en) | 1980-12-19 | 1980-12-19 | Reagent for measuring direct bilirubin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57103056A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3225331A1 (en) * | 1982-07-07 | 1984-01-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | METHOD FOR DETERMINING DIRECT AND TOTAL BILIRUBIN, AND REAGENT SUITABLE FOR THIS |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4929475A (en) * | 1972-07-19 | 1974-03-15 | ||
JPS5412840A (en) * | 1977-06-30 | 1979-01-30 | Canon Inc | Measuring method for surface potential of electrophotographic photoreceptor by time series |
JPS5544992A (en) * | 1978-09-22 | 1980-03-29 | Miles Lab | Apparatus for and method of detecting bilirubin in serum and method of producing same apparatus |
-
1980
- 1980-12-19 JP JP18105180A patent/JPS57103056A/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4929475A (en) * | 1972-07-19 | 1974-03-15 | ||
JPS5412840A (en) * | 1977-06-30 | 1979-01-30 | Canon Inc | Measuring method for surface potential of electrophotographic photoreceptor by time series |
JPS5544992A (en) * | 1978-09-22 | 1980-03-29 | Miles Lab | Apparatus for and method of detecting bilirubin in serum and method of producing same apparatus |
Also Published As
Publication number | Publication date |
---|---|
JPS57103056A (en) | 1982-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dangerfield et al. | Estimation of bilirubin in serum | |
Shetlar et al. | Determination of serum polysaccharides by the tryptophane reaction. | |
US4038031A (en) | Test composition, device and method for detecting bilirubin | |
Boxer et al. | Determination of thiocyanate in body fluids | |
US4892833A (en) | Process and a reagent kit for the determination of direct and total filirubin | |
US4224034A (en) | Assay of iron and iron binding protein reagents and methods | |
JPS6142823B2 (en) | ||
US4119401A (en) | Total bilirubin assay | |
JPH0473108B2 (en) | ||
JP3569139B2 (en) | Diazonium ion assay reagent and method of use | |
JPS61223651A (en) | Method for quantitative determination of bilirubin | |
JPS6322262B2 (en) | ||
US3528777A (en) | Process and compositions for determination of uric acid in blood serum | |
US3649198A (en) | Diagnostic method for the determination of uric acid in blood | |
US4030885A (en) | Bilirubin determination | |
US4965210A (en) | Stable reagent for determining bilirubin in serum and method of preparation | |
Bradbury | A simplified method for the estimation of sodium | |
Bidmead | A modified technique for determining uric acid in blood and urine | |
White et al. | Photometric studies on the diazo reaction for serum bilirubin | |
US6696297B2 (en) | Non-oxidizable bilirubin substitutes and uses therefor | |
Thompson et al. | Liquor volume by direct spectrophotometric determination of injected PAH | |
US3511611A (en) | Blood urea nitrogen test | |
Fleck et al. | The determination of bromsulphthalein in serum | |
RU2022270C1 (en) | Method of diabetes mellitus compensation determination in children | |
JPS6322263B2 (en) |